Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11471)
All Articles published online
|
Publishing Process of This Article
|
Aug 14, 2018 (publication date) through Mar 31, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Akcay IM, Katrinli S, Ozdil K, Doganay GD, Doganay L. Host genetic factors affecting hepatitis B infection outcomes: Insights from genome-wide association studies. World J Gastroenterol 2018; 24(30): 3347-3360 [PMID: 30122875 DOI: 10.3748/wjg.v24.i30.3347] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i30/3347.htm |
| Number | Citing Articles |
| 1 |
Julieta Trinks, Sebastián Marciano, Isabella Esposito, Alejandra Franco, Maria Florencia Mascardi, Manuel Mendizabal, Beatriz Livellara, Diego Arrigo, Pablo Calzetta, Claudia Vujacich, Diego Giunta, Adrián Gadano, Diego Flichman. The genetic variability of hepatitis B virus subgenotype F1b precore/core gene is related to the outcome of the acute infection. Virus Research 2020; 277: 197840 doi: 10.1016/j.virusres.2019.197840
|
| 2 |
Alexander J. Mentzer, Alexander T. Dilthey, Martin Pollard, Deepti Gurdasani, Emre Karakoc, Tommy Carstensen, Allan Muhwezi, Clare Cutland, Amidou Diarra, Ricardo da Silva Antunes, Sinu Paul, Gaby Smits, Susan Wareing, HwaRan Kim, Cristina Pomilla, Amanda Y. Chong, Debora Y. C. Brandt, Rasmus Nielsen, Samuel Neaves, Nicolas Timpson, Austin Crinklaw, Cecilia S. Lindestam Arlehamn, Anna Rautanen, Dennison Kizito, Tom Parks, Kathryn Auckland, Kate E. Elliott, Tara Mills, Katie Ewer, Nick Edwards, Segun Fatumo, Emily Webb, Sarah Peacock, Katie Jeffery, Fiona R. M. van der Klis, Pontiano Kaleebu, Pandurangan Vijayanand, Bjorn Peters, Alessandro Sette, Nezih Cereb, Sodiomon Sirima, Shabir A. Madhi, Alison M. Elliott, Gil McVean, Adrian V. S. Hill, Manjinder S. Sandhu. High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response. Nature Medicine 2024; 30(5): 1384 doi: 10.1038/s41591-024-02944-5
|
| 3 |
Shi Li, Yue Xi, Xue-Ying Dong, Wen-Bin Yuan, Jing-Feng Tang, Ce-Fan Zhou. Evaluating the scope of human leukocyte antigen polymorphisms influencing hepatitis B virus-related liver cancer and cirrhosis through multi-clustering analysis. World Journal of Gastroenterology 2025; 31(7): 102632 doi: 10.3748/wjg.v31.i7.102632
|
| 4 |
Alicja E. Grzegorzewska, Monika K. Świderska, Wojciech Marcinkowski, Adrianna Mostowska, Paweł P. Jagodziński. Polymorphism rs368234815 of interferon-λ4 gene and generation of antibodies to hepatitis B virus surface antigen in extracorporeal dialysis patients. Expert Review of Vaccines 2020; 19(3): 293 doi: 10.1080/14760584.2020.1745637
|
| 5 |
Nevin Varghese, Amry Majeed, Suraj Nyalakonda, Tina Boortalary, Dina Halegoua-DeMarzio, Hie-Won Hann. Review of Related Factors for Persistent Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Cancers 2024; 16(4): 777 doi: 10.3390/cancers16040777
|
| 6 |
Linghuan Wang, Binqi Li, He Zhao, Peixin Wu, Qingzhen Wu, Kang Chen, Yiming Mu. A systematic review and meta-analysis of endocrine-related adverse events associated with interferon. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.949003
|
| 7 |
Mei‐Hsuan Lee, Yu‐Han Huang. Editorial: genome‐wide association for developing chronic hepatitis B—authors’ reply. Alimentary Pharmacology & Therapeutics 2020; 52(6): 1085 doi: 10.1111/apt.15994
|
| 8 |
Niraj James Shah, Mark M Aloysius, Neil Rohit Sharma, Kumar Pallav. Advances in treatment and prevention of hepatitis B. World Journal of Gastrointestinal Pharmacology and Therapeutics 2021; 12(4): 56-78 doi: 10.4292/wjgpt.v12.i4.56
|
| 9 |
Xuan Xu, Qing-Ye Zhang, Xin-Yi Chu, Yuan Quan, Bo-Min Lv, Hong-Yu Zhang. Facilitating Antiviral Drug Discovery Using Genetic and Evolutionary Knowledge. Viruses 2021; 13(11): 2117 doi: 10.3390/v13112117
|
| 10 |
Peter Block, Brianna Shinn, Christopher Roth, Laurence Needleman, Ernest Rosato, Hie-Won Hann. Vagaries of the Host Response in the Development of Hepatitis B-related Hepatocellular Carcinoma: A Case Series. Current Cancer Therapy Reviews 2020; 16(3): 253 doi: 10.2174/1573394716666200129121051
|
| 11 |
Matthew Z. Dudley, Jennifer E. Gerber, Haley Budigan Ni, Madeleine Blunt, Taylor A. Holroyd, Bruce C. Carleton, Gregory A. Poland, Daniel A. Salmon. Vaccinomics: A scoping review. Vaccine 2023; 41(14): 2357 doi: 10.1016/j.vaccine.2023.02.009
|
| 12 |
Yu‐Han Huang, Shu‐Fen Liao, Seik‐Soon Khor, Yu‐Ju Lin, Hsuan‐Yu Chen, Ya‐Hsuan Chang, Yi‐Hsiang Huang, Sheng‐Nan Lu, Hye‐Won Lee, Wen‐Ya Ko, Claire Huang, Po‐Chun Liu, Yen‐Ju Chen, Ping‐Feng Wu, Hou‐Wei Chu, Pei‐Ei Wu, Katsushi Tokunaga, Chen‐Yang Shen, Mei‐Hsuan Lee. Large‐scale genome‐wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank. Alimentary Pharmacology & Therapeutics 2020; 52(4): 682 doi: 10.1111/apt.15887
|
| 13 |
Patricia T. Illing, Andy van Hateren, Rachel Darley, Nathan P. Croft, Nicole A. Mifsud, Samuel King, Lyudmila Kostenko, Mandvi Bharadwaj, James McCluskey, Tim Elliott, Anthony W. Purcell. Kinetics of Abacavir-Induced Remodelling of the Major Histocompatibility Complex Class I Peptide Repertoire. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.672737
|
| 14 |
Nagham Nafiz Hendi, Asma Mahdi, Randa AlYafie. Hepatitis - Recent Advances [Working Title]. 2025; doi: 10.5772/intechopen.1007793
|
| 15 |
Elizabeth Hamilton, Ling Yang, Alexander J. Mentzer, Yu Guo, Yiping Chen, Jun Lv, Robert Fletcher, Neil Wright, Kuang Lin, Robin Walters, Christiana Kartsonaki, Yingcai Yang, Sushila Burgess, Sam Sansome, Liming Li, Iona Y. Millwood, Zhengming Chen. Conventional and genetic risk factors for chronic Hepatitis B virus infection in a community-based study of 0.5 million Chinese adults. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-16360-7
|
| 16 |
Haibing Gao, Xiangmei Wang, Huaxi Ma, Shenglong Lin, Dongqing Zhang, Wenjun Wu, Ziyuan Liao, Mengyun Chen, Qin Li, Minghua Lin, Dongliang Li. METTL16 regulates m6A methylation on chronic hepatitis B associated gene HLA-DPB1 involved in liver fibrosis. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.996245
|
| 17 |
Abdul Malik, Fahad Aldakheel, Syed Rabbani, Meshal Alshehri, Anis Ahmad Chaudhary, Musaed Alkholief, Aws Alshamsan. LCR based quick detection of hotspot G1896A mutation in patients with different spectrum of hepatitis B. Journal of Infection and Public Health 2021; 14(5): 651 doi: 10.1016/j.jiph.2021.01.013
|
| 18 |
Niraj James Shah, Mark M Aloysius, Neil Rohit Sharma, Kumar Pallav. Advances in treatment and prevention of hepatitis B. World Journal of Gastrointestinal Pharmacology and Therapeutics 2021; 12(4): 56-78 doi: 10.4292/wjgpt.v12.i4.56
|
| 19 |
Danilo Di Bona, Janardan P. Pandey, Anna Aiello, Massimo Bilancia, Giuseppina Candore, Calogero Caruso, Claudia Colomba, Giovanni Duro, Mattia Emanuela Ligotti, Luigi Macchia, Sergio Rizzo, Giulia Accardi. The immunoglobulin γ marker 17 allotype and KIR/HLA genes prevent the development of chronic hepatitis B in humans. Immunology 2020; 159(2): 178 doi: 10.1111/imm.13133
|
| 20 |
Yu-Ju Chu, Hwai-I. Yang, Hui-Han Hu, Jessica Liu, Yu-Ling Lin, Chia-Ling Chang, Wen-Sheng Luo, Chin-Lan Jen, Chien-Jen Chen. HBV genotype-dependent association of HLA variants with the serodecline of HBsAg in chronic hepatitis B patients. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-27570-y
|
| 21 |
Zhenhua Zhang, Changtai Wang, Zhongping Liu, Guizhou Zou, Jun Li, Mengji Lu. Host Genetic Determinants of Hepatitis B Virus Infection. Frontiers in Genetics 2019; 10 doi: 10.3389/fgene.2019.00696
|
| 22 |
Safar M. Alqahtani, Ali Altharawi, Alhumaidi Alabbas, Faisal Ahmad, Hassan Ayaz, Asia Nawaz, Sidra Rahman, Manal A. Alossaimi. System biology approach to identify the novel biomarkers in glioblastoma multiforme tumors by using computational analysis. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1364138
|
| 23 |
Mahmoud F. Dondeti, Mohamed S. Abdelkhalek, Hosam M El-Din Elezawy, Walaa F. Alsanie, Bassem M. Raafat, Amira M. Gamal-Eldeen, Roba M. Talaat. Association between interferon-gamma (IFN-γ) gene polymorphisms (+874A/T and +2109A/G), and susceptibility to hepatitis B viral infection (HBV). Journal of Applied Biomedicine 2022; 20(1): 37 doi: 10.32725/jab.2022.001
|
| 24 |
Guo-Qing Yin, Ke-Ping Chen, Xiao-Chun Gu. Heterogeneity of immune control in chronic hepatitis B virus infection: Clinical implications on immunity with interferon-α treatment and retreatment. World Journal of Gastroenterology 2022; 28(40): 5784-5800 doi: 10.3748/wjg.v28.i40.5784
|
| 25 |
Ganesh Selvaraj Duraisamy, Dattatry Bhosale, Ivana Lipenská, Ivana Huvarova, Daniel Růžek, Marc P. Windisch, Andrew D. Miller. Advanced Therapeutics, Vaccinations, and Precision Medicine in the Treatment and Management of Chronic Hepatitis B Viral Infections; Where Are We and Where Are We Going?. Viruses 2020; 12(9): 998 doi: 10.3390/v12090998
|
| 26 |
Shulin Xia, Jiachen Ding, Zhenhua Zhang, Xu Li, Jianhe Gan, Xiaomin He. Cluster of Differentiation 24 Polymorphism Has No Significant Association with Chronic Hepatitis B Virus Infection in the Chinese Han Population: A Family-Based Association Study. Infection and Drug Resistance 2022; : 4837 doi: 10.2147/IDR.S368392
|
| 27 |
Bart van Hoek. Editorial: genome‐wide association studies for developing chronic hepatitis B. Alimentary Pharmacology & Therapeutics 2020; 52(6): 1083 doi: 10.1111/apt.15960
|
| 28 |
Majid Eslami, Neda Arjmand, Fatemeh Mahmoudian, Ali Babaeizad, Hamed Tahmasebi, Fahimeh Fattahi, Valentyn Oksenych. Deciphering Host–Virus Interactions and Advancing Therapeutics for Chronic Viral Infection. Viruses 2025; 17(3): 390 doi: 10.3390/v17030390
|
| 29 |
María B Pisano, Cecilia G Giadans, Diego M Flichman, Viviana E Ré, María V Preciado, Pamela Valva. Viral hepatitis update: Progress and perspectives . World Journal of Gastroenterology 2021; 27(26): 4018-4044 doi: 10.3748/wjg.v27.i26.4018
|
| 30 |
Fernando Cezar-dos-Santos, João Paulo Assolini, Nádia Calvo Martins Okuyama, Kelvinson Fernandes Viana, Karen Brajão de Oliveira, Eiko Nakagawa Itano. Unraveling the susceptibility of paracoccidioidomycosis: Insights towards the pathogen-immune interplay and immunogenetics. Infection, Genetics and Evolution 2020; 86: 104586 doi: 10.1016/j.meegid.2020.104586
|
| 31 |
Duaa W. Al-Sadeq, Sara A. Taleb, Roan E. Zaied, Sara M. Fahad, Maria K. Smatti, Balsam R. Rizeq, Asmaa A. Al Thani, Hadi M. Yassine, Gheyath K. Nasrallah. Hepatitis B Virus Molecular Epidemiology, Host-Virus Interaction, Coinfection, and Laboratory Diagnosis in the MENA Region: An Update. Pathogens 2019; 8(2): 63 doi: 10.3390/pathogens8020063
|
| 32 |
Kasem Kulkeaw, Worakamol Pengsart. Progress and Challenges in the Use of a Liver-on-a-Chip for Hepatotropic Infectious Diseases. Micromachines 2021; 12(7): 842 doi: 10.3390/mi12070842
|
| 33 |
Sheng-Han Wang, Shiou-Hwei Yeh, Pei-Jer Chen. Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance. Cancers 2021; 13(10): 2454 doi: 10.3390/cancers13102454
|
| 34 |
Hai Cheng, Yaoling Ouyang, Chengbin Li. Impact of IRGM gene promoter polymorphisms on susceptibility to chronic HBV infection. International Journal of Immunogenetics 2024; 51(3): 149 doi: 10.1111/iji.12661
|
| 35 |
Yang Yuan, Vedant V. Bodke, Christine Lin, Shang Gao, Jalees Rehman, Jisu Li, Salman R. Khetani. Long-term HBV infection of engineered cultures of induced pluripotent stem cell-derived hepatocytes. Hepatology Communications 2024; 8(8) doi: 10.1097/HC9.0000000000000506
|
| 36 |
Fang Chen, Netanel Tzarum, Ian A Wilson, Mansun Law. VH1-69 antiviral broadly neutralizing antibodies: genetics, structures, and relevance to rational vaccine design. Current Opinion in Virology 2019; 34: 149 doi: 10.1016/j.coviro.2019.02.004
|
| 37 |
Jun Wu, Meihong Han, Jia Li, Xiaoli Yang, Dongliang Yang. Hepatitis B Virus Infection. Advances in Experimental Medicine and Biology 2020; 1179: 71 doi: 10.1007/978-981-13-9151-4_4
|
| 38 |
Saeideh Ashouri, Seik-Soon Khor, Yuki Hitomi, Hiromi Sawai, Nao Nishida, Masaya Sugiyama, Yosuke Kawai, Nawarat Posuwan, Pisit Tangkijvanich, Piyawat Komolmit, Makoto Tsuiji, Vorasuk Shotelersuk, Yong Poovorawan, Masashi Mizokami, Katsushi Tokunaga. Genome-Wide Association Study for Chronic Hepatitis B Infection in the Thai Population. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.887121
|
| 39 |
Tawatchai Apidechkul. Seroprevalence and factors associated with hepatitis B virus infection among the hill tribe youths, northern Thailand. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-3747-3
|
| 40 |
Kehui Liu, Liwen Chen, Gangde Zhao, Zhujun Cao, Fengdi Li, Lanyi Lin, Chuanwu Zhu, Qing Xie, Yumin Xu, Shisan Bao, Hui Wang. IPS-1 polymorphisms in regulating interferon response in HBV infection. BioScience Trends 2019; 13(2): 130 doi: 10.5582/bst.2018.01304
|
| 41 |
Mohammad Enamul Hoque Kayesh, Md Abul Hashem, Takahiro Sanada, Bouchra Kitab, Md Haroon Or Rashid, Lipi Akter, Sayeh Ezzikouri, Shuko Murakami, Shintaro Ogawa, Yasuhito Tanaka, Michinori Kohara, Kyoko Tsukiyama-Kohara. Characterization of innate immune response to hepatitis B virus genotype F acute infection in tree shrew (Tupaia belangeri) model. Frontiers in Virology 2022; 2 doi: 10.3389/fviro.2022.926831
|
| 42 |
Anran Tian, Yuwen Li, Haozhi Fan, Pingping Hu, Ruirui Xu, Hui Yuan, Jinyuan Cai, Wen Zhang, Ming Yue, Jun Li, Chen Dong, Chuanlong Zhu. Association of Elongation Factor Tu GTP-binding Domain-containing 2 Gene (EFTUD2) Polymorphism with the Risk of Hepatitis B Virus Infection. Immunological Investigations 2022; 51(5): 1485 doi: 10.1080/08820139.2021.1970763
|
| 43 |
Béatrice Laupèze, Ventzislav Vassilev, Selim Badur. A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatments. Expert Review of Gastroenterology & Hepatology 2023; 17(11): 1135 doi: 10.1080/17474124.2023.2268503
|
| 44 |
Magda Rybicka, Anna Woziwodzka, Alicja Sznarkowska, Tomasz Romanowski, Piotr Stalke, Marcin Dręczewski, Eloi R. Verrier, Thomas F. Baumert, Krzysztof Piotr Bielawski. Liver Cirrhosis in Chronic Hepatitis B Patients Is Associated with Genetic Variations in DNA Repair Pathway Genes. Cancers 2020; 12(11): 3295 doi: 10.3390/cancers12113295
|
| 45 |
Kwesi Z Tandoh, Osbourne Quaye. Genetic Associations in Chronic Hepatitis B Infection: Toward Developing Polygenic Risk Scores. Future Microbiology 2022; 17(7): 541 doi: 10.2217/fmb-2021-0176
|
| 46 |
Ambika Sharma, Ajay Duseja, Jyoti Parkash, Harish Changotra. Association of IRGM gene promoter polymorphisms with hepatitis B virus infection. The Journal of Gene Medicine 2022; 24(7) doi: 10.1002/jgm.3433
|
| 47 |
Jiamin Qiu, Shiwen Zhang, Yonghui Feng, Xin Su, Jun Cai, Shiyun Chen, Jiazi Liu, Shiqi Huang, Haokun Huang, Sui Zhu, Huiyan Wen, Jiaxin Li, Haoyu Yan, Zhiquan Diao, Xiaofeng Liang, Fangfang Zeng. Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analyses. Expert Review of Vaccines 2024; 23(1): 69 doi: 10.1080/14760584.2023.2289566
|